Display options
Cite
Khanna N, Stuehler C, Lünemann A, et al. Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk. Swiss Med Wkly. 2016;146:w14350doi: 10.4414/smw.2016.14350.
Khanna, N., Stuehler, C., Lünemann, A., Wójtowicz, A., Bochud, P. Y., & Leibundgut-Landmann, S. (2016). Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk. Swiss medical weekly, 146w14350. https://doi.org/10.4414/smw.2016.14350
Khanna, Nina, et al. "Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk." Swiss medical weekly vol. 146 (2016): w14350. doi: https://doi.org/10.4414/smw.2016.14350
Khanna N, Stuehler C, Lünemann A, Wójtowicz A, Bochud PY, Leibundgut-Landmann S. Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk. Swiss Med Wkly. 2016 Sep 21;146:w14350. doi: 10.4414/smw.2016.14350. eCollection 2016. PMID: 27655228.
Copy Download .nbib Format: NLM
Share it on

Swiss Med Wkly. 2016 Sep 21;146:w14350. doi: 10.4414/smw.2016.14350. eCollection 2016.

Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk.

Swiss medical weekly

Nina Khanna, Claudia Stuehler, Anna Lünemann, Agnieszka Wójtowicz, Pierre-Yves Bochud, Salomé Leibundgut-Landmann

Affiliations

  1. Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Switzerland; Infection Biology Laboratory, Department of Biomedicine, University and University Hospital Basel, Switzerland.
  2. Infection Biology Laboratory, Department of Biomedicine, University and University Hospital Basel, Switzerland.
  3. Experimental Infectious Diseases and Cancer Research, University Children's Hospital, Zürich, Switzerland.
  4. Infectious Diseases Service, University Hospital and University of Lausanne, Switzerland.
  5. Section of Immunology, Vetsuisse Faculty, University of Zürich, Switzerland.

PMID: 27655228 DOI: 10.4414/smw.2016.14350

Abstract

In spite of the ever-increasing incidence and poor outcome of invasive fungal infections in immune compromised patients, there is currently no reliable method to accurately predict the risk, to monitor the outcome and to treat these infections. Protective immunity against Candida and Aspergillus depends on a highly coordinated interaction between the innate and adaptive immune systems. Genetic and immunological defects in components of these networks result in increased risk of invasive fungal infections among patients undergoing chemotherapy or transplant recipients. We review the most important genetic and immunological factors that influence human susceptibility to Candida and Aspergillus infections and discuss the potential role of basic research to promote precision medicine for infectious diseases. We discuss how immunogenetic studies can help to provide tools for improved identification of high-risk patients and the development of tailored antifungal therapies.

Publication Types

Grant support